RPR-105735B

N/A

Report date: 2023/10/10 16:12:53

Base Information

Drug NameRPR-105735B

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonists

TargetsCysteinyl leukotriene receptor 1

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A